American Society of Clinical Oncology Issues Statement on Nomination of Hahn to Serve as FDA Commissioner
November 01, 2019
November 01, 2019
ALEXANDRIA, Virginia, Nov. 1 -- The American Society of Clinical Oncology issued the following statement by President Howard A. "Skip" Burris III:
"The American Society of Clinical Oncology (ASCO) congratulates Stephen M. Hahn, MD, FASTRO, on his nomination by President Trump to serve as the next Commissioner of the Food and Drug Administration (FDA). An oncologist and long-time member of ASCO, Dr. Hahn currently serves as the Chief Medical Executive at The University . . .
"The American Society of Clinical Oncology (ASCO) congratulates Stephen M. Hahn, MD, FASTRO, on his nomination by President Trump to serve as the next Commissioner of the Food and Drug Administration (FDA). An oncologist and long-time member of ASCO, Dr. Hahn currently serves as the Chief Medical Executive at The University . . .